Guangdong has included 1,655 types of traditional Chinese medicine tablets into the scope of medical insurance payment.
Reporter 9 from the first press office of Guangdong held a press conference on “on further promoting the high-quality development of biomedical industry in Guangdong action program” (hereinafter referred to as “program”) was informed that at present, Guangdong has 1655 kinds of traditional Chinese medicine tablets into the scope of payment of medical insurance.
Guangdong first medical security bureau relevant person in charge of the conference back to manage the reporter's question, said Guangdong will speed up the promotion and application of innovative drugs, in a comprehensive, rapid implementation of the national health insurance drug catalog and landing of the national drug at the same time, through the eligible Chinese medicine tablets into the scope of payment of Guangdong Province health insurance, to promote the “Internet +” medical services health insurance payment work and other policy measures to actively promote the development of the biomedical industry, and to promote the development of biomedical industry. At the same time, it has actively promoted the development of the biomedical industry through the inclusion of eligible Chinese medicine tablets in the scope of payment under Guangdong Province's medical insurance and the promotion of “Internet Plus” medical services.
Among other things, Guangdong has promptly included all medicines in the national health insurance drug catalog in the scope of provincial health insurance payment, and has added Chinese medicine tablets in accordance with the procedure, so as to realize that they should be included as much as possible, and to meet the demand for Chinese medicine services of the insured population; at present, Guangdong has included 1,655 types of Chinese medicine tablets (of which 494 types of Chinese medicine formulae are granules) in the scope of payment for health insurance, including wall-breaking tablets, lyophilized powders and other types of dosage forms.
At the same time, Guangdong actively supports qualified medical insurance designated medical institutions to carry out “Internet+” medical services. First, the consultation fees and drug costs incurred by insured patients with chronic diseases and common diseases for “Internet+” follow-up consultations are included in the scope of medical insurance payment, including the costs incurred by insured patients for the use of innovative drugs newly included in the medical insurance drug catalog, which will be paid by the medical insurance fund in accordance with the regulations. Supporting participants to enjoy “Internet+” chronic disease medical services, and implementing unified management of online and offline medical services for “Internet+” medical services in principle. The medical insurance fund will pay the prescribed consultation fees and drug fees incurred by participants in the designated medical institutions for “Internet+” medical services in this coordinating region for follow-up consultations and the issuance of prescriptions, in accordance with the ratio stipulated below the line in this coordinating region, so as to facilitate online medical treatment and the purchase of medicines by insured persons.
Secondly, the eligible Internet diagnosis and treatment projects will be included in the scope of medical insurance payment. It is reported that Guangdong is currently unified implementation of the “Guangdong Province basic medical insurance, industrial injury insurance and maternity insurance diagnosis and treatment projects catalog”, has a variety of Internet diagnosis and treatment projects into the scope of payment of medical insurance, such as “online medical consultation diagnosis and treatment” “remote consultation”, etc. Participants use the medical insurance diagnosis and treatment projects within the catalog, the medical insurance fund will be paid in accordance with the provisions of the medical insurance. “The medical insurance fund will pay for the diagnosis and treatment items in the catalog of medical insurance diagnosis and treatment items in accordance with the regulations.
